Cadrenal Therapeutics Analyst Ratings
BenzingaMar 14 07:30 ET
Analysts Conflicted on These Healthcare Names: Cadrenal Therapeutics, Inc. (CVKD), Protara Therapeutics (TARA) and Spruce Biosciences (SPRB)
TipRanksMar 14 06:30 ET
Cadrenal Therapeutics, Inc. (CVKD) Receives a Buy From Noble Financial
TipRanksMar 13 08:05 ET
Noble Capital Markets Initiates Coverage On Cadrenal Therapeutics With Outperform Rating, Announces Price Target of $4
BenzingaDec 18, 2023 09:09 ET
Cadrenal Therapeutics Analyst Ratings
BenzingaDec 18, 2023 09:07 ET
HC Wainwright & Co. Initiates Coverage On Cadrenal Therapeutics With Buy Rating, Announces Price Target of $3
BenzingaNov 20, 2023 07:05 ET
Cadrenal Therapeutics Analyst Ratings
BenzingaNov 20, 2023 07:04 ET
No Data
No Data